Search Results | DrugBank Online

Displaying drugs 8126 - 8150 of 10587 in total

TERT-BUTYL 2-CYANO-2-METHYLHYDRAZINECARBOXYLATE

Experimental

Dimethylthiambutene

Dimethylthiambutene (N,N-Dimethyl-1-methyl-3,3-di-2-thienylallylamine, Dimethibutin, Ohton) is an opioid analgesic drug. It is now under international control under Schedule I of the UN Single Convention On Narcotic Drugs 1961, presumably due to high abuse potential, although little more information is available.

Experimental

Illicit

Treprostinil palmitil

Investigational

Tricarbonyl(1,10-phenanthroline)rhenium(1+)

Experimental

Teprasiran

Teprasiran is under investigation in clinical trial NCT03510897 (QPI-1002 Phase 3 for Prevention of Major Adverse Kidney Events (MAKE) in Subjects at High Risk for AKI Following Cardiac Surgery).

Investigational

EI-001

Investigational

TTX-siPDL1

TTX-siPDL1 is an siRNA-based modulator of programmed death-ligand 1.

Investigational

Arimoclomol

Arimoclomol is an experimental drug compound developed by CytRx Corporation, a biopharmaceutical company based in Los Angeles, California. The orally administered drug is intended to treat amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, a neurodegenerative disease with no effective treatment.

Investigational